Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML

被引：76
|
作者：
Summers, K. [1 ]
Stevens, J.
Kakkas, I.
Smith, M.
Smith, L. L.
MacDougall, F.
Cavenagh, J.
Bonnet, D.
Young, B. D.
机构：
[1] Barts & London Queen Marys Sch Med & Dent, Ctr Med Oncol, London, England
[2] Guys Hosp, Dept Hematol, London, England
[3] St Bartholomews Hosp, Dept Hematol, London, England
[4] Canc Res UK, London Res Inst, Haematopoiet Stem Cell Lab, London, England
来源：
LEUKEMIA | 2007年 / 21卷 / 03期
关键词：
D O I：
10.1038/sj.leu.2404514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：550 / 551
页数：2
相关论文
共 50 条
  • [21] FLT3-ITD Mutation in MDS Patients Is Associated with Early Transformation to AML
    Sumiyoshi, Ritsu
    Tashiro, Haruko
    Matsuo, Takuji
    Yamamoto, Tadashi
    Oka-Miura, Yoko
    Matsumoto, Kensuke
    Ooi, Jun
    Shirafuji, Naoki
    BLOOD, 2017, 130
  • [22] Identification of FLT3-ITD mutations in AML patients using different diagnostic methods
    Anta-Szalmas, P.
    Koczok, K.
    Balogh, I.
    Kiss, A.
    Udvardy, M.
    Kappelmayer, J.
    BLOOD REVIEWS, 2007, 21 : S110 - S110
  • [23] Allogeneic stem cell transplantation reduces the relapse incidence in patients with AML and normal karyotype independently of the FLT3-ITD status
    Schueller, F.
    Maschmeyer, G.
    Fischer, T.
    Herold, M.
    Sayer, H. G.
    Wolf, H. -H.
    Kreibich, U.
    Haehling, D.
    Doelken, G.
    Junghanss, C.
    Grobe, N.
    Krahl, R.
    Lange, T.
    Al Ali, H. -K.
    Basara, N.
    Poenisch, W.
    Niederwieser, D.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S39 - S40
  • [24] MtSS 1 is a novel indicator of superior survival in normal karyotype AML and is specifically induced by AML1-ETO but suppressed by Flt3-ITD
    Klaile, Y.
    Schemionek, M.
    Krug, U.
    Dugas, M.
    Bruemmendorf, T. H.
    Berdel, W. E.
    Mueller-Tidow, C.
    Koschmieder, S.
    ONKOLOGIE, 2013, 36 : 193 - 193
  • [25] Acquired uniparental disomy for chromosome 13 is common and associated with FLT3-itd mutations in AML
    Griffiths, M.
    Mason, J.
    McMullan, D.
    Akiki, S.
    Stinton, V.
    Rindl, M.
    Bryon, J.
    Ely, A.
    CHROMOSOME RESEARCH, 2005, 13 : 170 - 170
  • [26] Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature
    Giacomo Volpe
    David S. Walton
    David E. Grainger
    Carl Ward
    Pierre Cauchy
    Daniel Blakemore
    Daniel J. L. Coleman
    Peter N. Cockerill
    Paloma Garcia
    Jon Frampton
    Scientific Reports, 7
  • [27] Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature
    Volpe, Giacomo
    Walton, David S.
    Grainger, David E.
    Ward, Carl
    Cauchy, Pierre
    Blakemore, Daniel
    Coleman, Daniel J. L.
    Cockerill, Peter N.
    Garcia, Paloma
    Frampton, Jon
    SCIENTIFIC REPORTS, 2017, 7
  • [28] Impact of FLT3-ITD mutations on the outcome of patients allografted with partial T-cell depleted grafts for AML in first complete remission with normal karyotype
    Beauverd, Y.
    Roosnek, E.
    Simon, A.
    Tirefort, Y.
    Grandjean, A. -P.
    Tsopra, O.
    Dantin, C.
    Masouridi-Levrat, S.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S485 - S485
  • [29] FLT3-ITD Incidence and FLT-D835 Mutations in Acute Myeloid Leukemia Patients with Normal Karyotype in Morocco: A Preliminary Study
    Dehbi, Hind
    Kassogue, Yaya
    Nasserddine, Sanaa
    Quessar, Asma
    Nadifi, Sellama
    MIDDLE EAST JOURNAL OF CANCER, 2013, 4 (01) : 1 - 5
  • [30] Rising Percentages of Blasts Are Associated with Continuously Increasing Frequencies of FLT3-ITD and NPM1 Mutations In AML and In Addition Depend on Combinations of These Markers: Analysis of 805 Cases with Normal Karyotype AML
    Haferlach, Torsten
    Bacher, Ulrike
    Alpermann, Tamara
    Haferlach, Claudia
    Kern, Wolfgang
    Schnittger, Susanne
    BLOOD, 2010, 116 (21) : 458 - 459
12345